MIRACLE Medical Technology Act of 2025
Sponsor

Full profile: /officials/B001260
Source: Congress.gov · FEC
Cosponsors (3)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Committee Activity
Currently in
- House Committee on Energy and CommerceReferred To · 2025-01-23
Previously
- Energy and Commerce CommitteeReferred To · 2025-01-23
Plain-English Summary
Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025 This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program’s purposes.
Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR5347Health Care Efficiency Through Flexibility ActReported by Committee · 2026-05-21
- HR8959Semiconductor Superiority ActReferred to Committee · 2026-05-21
- HR7786AI Fraud Accountability ActReferred to Committee · 2026-03-04
- HR6513MINKS are Superspreaders ActReferred to Committee · 2026-01-13